Public consultation SCENIHR Opinion on the Safety of Human-derived Products with regard to Variant Creutzfeldt- Jakob Disease
The SCENIHR undertook
a public consultation on the
basis of an
opinion
adopted on 28-29 September
2005 on the Safety of
Human-derived Products with
regard to Variant
Creutzfeldt-Jakob Disease.
Interested parties were
invited to submit comments
and pertinent scientific
information by e-mail by 10
February 2006.
Following comments from
the public consultation
the opinion
was modified and
adopted by the SCENIHR during
the 11th plenary meeting of
11-12 May 2006.
The
Synthesis Reportpresents the
overall results from the
public consultation including
the SCENIHR responses.
The following
public
comments
were received by the
SCENIHR.
adopted on 28-29 September
2005 on the Safety of
Human-derived Products with
regard to Variant
Creutzfeldt-Jakob Disease.
Interested parties were
invited to submit comments
and pertinent scientific
information by e-mail by 10
February 2006.
were received by the
SCENIHR.
